Document is current
Any future updates will be listed below
-
Authors
Koppe, Uwe http://orcid.org/0000-0001-9718-5811
Marcus, Ulrich
Albrecht, Stefan
Jansen, Klaus
Jessen, Heiko
Gunsenheimer-Bartmeyer, Barbara
Bremer, Viviane
- License Information
-
More Information
Article History
Received: 4 May 2020
Accepted: 5 January 2021
First Online: 19 January 2021
Ethics approval and consent to participate
: This study was approved by the ethics commission of the Berlin Chamber of Physicians (Ref: Eth-14/18). All participants had to provide informed consent through the survey website before starting the survey.
: Not applicable.
: HJ received payment for study cost from Gilead Sciences Inc. UK owns ‘Exchange-traded fund’ (ETF) shares, which may include stocks of pharmaceutical companies that produce or develop PrEP. The other authors declare no conflicts of interest.
